SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-167307
Filing Date
2017-05-11
Accepted
2017-05-11 16:16:44
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d392617ds3.htm S-3 424150
2 EX-1.2 d392617dex12.htm EX-1.2 195166
3 EX-4.6 d392617dex46.htm EX-4.6 331358
4 EX-4.8 d392617dex48.htm EX-4.8 98889
5 EX-4.9 d392617dex49.htm EX-4.9 100439
6 EX-4.10 d392617dex410.htm EX-4.10 90468
7 EX-5.1 d392617dex51.htm EX-5.1 28471
8 EX-23.1 d392617dex231.htm EX-23.1 1591
9 GRAPHIC g392617g0509130455010.jpg GRAPHIC 6487
10 GRAPHIC g392617g0509130455197.jpg GRAPHIC 2014
11 GRAPHIC g392617g0509134414442.jpg GRAPHIC 6487
12 GRAPHIC g392617g0509134414626.jpg GRAPHIC 2014
13 GRAPHIC g392617g0509140949406.jpg GRAPHIC 2722
  Complete submission text file 0001193125-17-167307.txt   1299682
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-217889 | Film No.: 17834492
SIC: 2834 Pharmaceutical Preparations